Open AccessREVERSE SEROCONVERSION OF HEPATITIS B AFTER ALLOGENEIC BONE MARROW TRANSPLANTATION
Author(s) -
Nathalie Dhédin,
Catherine Douvin,
Mathieu Kuentz,
M. Marc,
Oumédaly Reman,
Claire Rieux,
Françoise Bernaudin,
Françoise Norol,
C Cordonnier,
D Bobin,
J M Métreau,
JP Vernant
Publication year - 1998
Publication title -
transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.45
H-Index - 204
eISSN - 1534-6080
pISSN - 0041-1337
DOI - 10.1097/00007890-199809150-00012
Subject(s) - medicine , seroconversion , hepatitis b virus , hepatitis b , immunology , immunosuppression , serology , antigen , transplantation , hepatitis , bone marrow , antibody , virology , virus
Reverse seroconversion to hepatitis B virus (HBV), i.e., HBV reactivation in patients with pretransplant antibodies to hepatitis B surface antigen (anti-HBs) and to hepatitis B core antigen (anti-HBc), is rarely re-ported after allogeneic bone marrow transplantation.